CN104610381B - 二茂铁吡啶衍生物及其合成方法和应用 - Google Patents
二茂铁吡啶衍生物及其合成方法和应用 Download PDFInfo
- Publication number
- CN104610381B CN104610381B CN201510048462.5A CN201510048462A CN104610381B CN 104610381 B CN104610381 B CN 104610381B CN 201510048462 A CN201510048462 A CN 201510048462A CN 104610381 B CN104610381 B CN 104610381B
- Authority
- CN
- China
- Prior art keywords
- ferrocene
- pyridine derivate
- fel1
- application
- aminopyridines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001308 synthesis method Methods 0.000 title abstract 2
- -1 Ferrocene pyridine derivatives Chemical class 0.000 title description 3
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical class [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 claims abstract description 78
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 122
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 60
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 24
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 claims description 22
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 16
- GTCAXTIRRLKXRU-UHFFFAOYSA-N carbamic acid methyl ester Natural products COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000004448 titration Methods 0.000 claims description 12
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N DMSO-d6 Substances [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 230000005311 nuclear magnetism Effects 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000012321 sodium triacetoxyborohydride Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 238000002798 spectrophotometry method Methods 0.000 claims description 7
- 239000012043 crude product Substances 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 238000010898 silica gel chromatography Methods 0.000 claims description 6
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 208000035126 Facies Diseases 0.000 claims description 4
- 239000007832 Na2SO4 Substances 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 208000011117 substance-related disease Diseases 0.000 claims description 4
- 150000002118 epoxides Chemical class 0.000 claims 1
- 239000012279 sodium borohydride Substances 0.000 claims 1
- 229910000033 sodium borohydride Inorganic materials 0.000 claims 1
- 150000003222 pyridines Chemical class 0.000 abstract 2
- 239000010949 copper Substances 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000000523 sample Substances 0.000 description 15
- 230000008859 change Effects 0.000 description 13
- 229910001430 chromium ion Inorganic materials 0.000 description 12
- 229910021645 metal ion Inorganic materials 0.000 description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 229910001431 copper ion Inorganic materials 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- 238000000954 titration curve Methods 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 238000010189 synthetic method Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 238000004847 absorption spectroscopy Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000011651 chromium Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000000215 hyperchromic effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 101710138657 Neurotoxin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- 239000011636 chromium(III) chloride Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- RDRCCJPEJDWSRJ-UHFFFAOYSA-N pyridine;1h-pyrrole Chemical compound C=1C=CNC=1.C1=CC=NC=C1 RDRCCJPEJDWSRJ-UHFFFAOYSA-N 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
- G01N21/79—Photometric titration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- High Energy & Nuclear Physics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Pyridine Compounds (AREA)
Abstract
本发明提供了两种二茂铁吡啶衍生物及其合成方法,其中,二茂铁单臂吡啶衍生物FeL1和二茂铁双臂吡啶衍生物FeL2可用于Cu2+和Cr3+的检测。
Description
技术领域
本发明涉及重金属离子的检测探针,尤其涉及一种二茂铁吡啶衍生物及其合成方法和应用。
背景技术
金属离子在自然环境和生物体内广泛分布,在生命活动中起着重要作用,同时金属离子环境污染也是世界各国关注的重点。铜是重金属元素之一,当生物体内浓度过高时,则会产生对一些必须酶的抑制作用、生物氧化、还原过程异常、神经毒素等有害作用。当人体内残存了大量的重金属铜之后,极易对身体内的脏器造成负担,特别是肝和胆,当这两种器官出现问题后,维持人体内的新陈代谢就会出现紊乱,导致肝硬化、肝腹水甚至更为严重。铬具有很强的富集作用,过量会使人中毒。因此如何有效地检测铜离子和铬离子对于环境科学、生物科学以及医学中都有着重要意义。
二茂铁衍生物具有较强的细胞生物活性,可抑制癌细胞生长,有望发展为新的抗癌药物,同时由于二茂铁及其衍生物容易进行化学修饰,因此二茂铁衍生物作为金属离子探针有着很大的优势。
发明内容
有鉴于此,本发明的在于提供一种可用作金属离子探针的二茂铁吡啶衍生物及其合成方法和应用。
本发明一方面提供了一种二茂铁吡啶衍生物,其化学结构式为:
二茂铁单臂吡啶衍生物FeL1。
本发明第二方面提供了所述二茂铁单臂吡啶衍生物FeL1的合成方法,其包括:将二茂铁甲醛在三乙酰氧基硼氢化钠作用下,与2-氨基甲酸甲酯基-6-氨基吡啶反应得到。
本发明第三方面提供了一种二茂铁吡啶衍生物,其化学结构式为:
二茂铁双臂吡啶衍生物FeL2。
本发明第四方面提供了所述二茂铁双臂吡啶衍生物FeL2的合成方法,其包括:将二茂铁二甲醛在三乙酰氧基硼氢化钠作用下,与2-氨基甲酸甲酯基-6-氨基吡啶反应得到。
本发明第五方面提供了上述两种二茂铁吡啶衍生物在Cu2+和Cr3+的检测中的应用。
本发明的有益效果是:本发明提供了二茂铁吡啶衍生物FeL1和FeL2及其制备方法,并应用于Cu2+和Cr3+的检测。
附图说明
图1为实施例三的紫外滴定曲线图;
图2为实施例四的紫外滴定曲线图;
图3为实施例五的紫外滴定曲线图;
图4为实施例六的核磁氢谱滴定图;
图5为实施例七的核磁氢谱滴定图;
图6为实施例八的核磁氢谱滴定图。
具体实施方式
本发明一方面提供了一种二茂铁吡啶衍生物,其化学结构式为:
二茂铁单臂吡啶衍生物FeL1。
本发明第二方面提供了所述二茂铁单臂吡啶衍生物FeL1的合成方法,其包括:将二茂铁甲醛在三乙酰氧基硼氢化钠作用下,与2-氨基甲酸甲酯基-6-氨基吡啶反应得到。
二茂铁单臂吡啶衍生物FeL1的制备反应过程如下:
优选的,所述二茂铁单臂吡啶衍生物FeL1的制备方法包括以下步骤:
a)将二茂铁甲醛和2-氨基甲酸甲酯基-6-氨基吡啶溶于干燥的CH2Cl2;
b)加入三乙酰氧基硼氢化钠;
c)加入三乙胺,调节pH为5-6;
d)加热回流过夜,反应结束后冷却,旋蒸,去除CH2Cl2溶解残留物得到橙黄色固体粗产物;
e)硅胶柱层析纯化,干燥后得到淡黄色固体。
本发明第三方面提供了一种二茂铁吡啶衍生物,其化学结构式为:
二茂铁双臂吡啶衍生物FeL2。
本发明第四方面提供了所述二茂铁双臂吡啶衍生物FeL2的合成方法,其包括:将二茂铁二甲醛在三乙酰氧基硼氢化钠作用下,与2-氨基甲酸甲酯基-6-氨基吡啶反应得到。
二茂铁双臂吡啶衍生物FeL2的制备反应过程如下:
优选的,所述二茂铁双臂吡啶衍生物FeL2的制备方法包括以下步骤:
a)将二茂铁二甲醛和2-氨基甲酸甲酯基-6-氨基吡啶溶于干燥的CH2Cl2;
b)加入三乙酰氧基硼氢化钠;
c)加入三乙胺,调节pH为5-6;
d)加热回流过夜,反应结束后冷却,旋蒸,去除CH2Cl2溶解残留物得到橙黄色固体粗产物;
e)硅胶柱层析纯化,干燥后得到淡黄色固体。
本发明第五方面提供了上述两种二茂铁吡啶衍生物在Cu2+和Cr3+的检测中的应用。具体的,一方面,可采用紫外分光光度法检测Cu2+和Cr3+;另一方面,也可采用核磁滴定法检测Cu2+和Cr3+。优选的,所述核磁滴定法在氘代甲醇,或者氘代甲醇和DMSO-d6混合溶液中进行。
以下结合具体实施例详细介绍本发明的二茂铁吡啶衍生物的合成方法及其应用。
实施例一
二茂铁单臂吡啶衍生物FeL1的合成
将0.6mmol二茂铁甲醛和0.7mmol 2-氨基甲酸甲酯基-6-氨基吡啶搅拌溶于25ml干燥的CH2Cl2,加入1.9mmol三乙酰氧基硼氢化钠,用三乙胺调节pH为5-6,加热回流过夜,将反应体系冷却至室温,旋蒸,CH2Cl2溶解残留物依次用饱和NaHCO3溶液,饱和NaCl溶液,H2O洗涤有机相,无水Na2SO4干燥,过滤旋蒸,得到橙黄色固体粗产物,用hexene/EtOAC=3∶1(v/v)作为淋洗剂,硅胶柱层析纯化,真空干燥后得到76.7mg淡黄色固体。
实施例二
二茂铁双臂吡啶衍生物FeL2的合成
将0.5mmol二茂铁二甲醛和1.3mmol 2-氨基甲酸甲酯基-6-氨基吡啶搅拌溶于50ml干燥的CH2Cl2,加入3mmol三乙酰氧基硼氢化钠,用三乙胺调节pH为5-6,加热回流夜,冷却至室温,旋蒸,CH2Cl2溶解残留物依次用饱和NaHCO3溶液,饱和NaCl溶液,H2O洗涤有机相,无水Na2SO4干燥,过滤旋蒸,得到橙黄色固体粗产物,用hexene/EtOAC=3∶1(v/v)作为淋洗剂,硅胶柱层析纯化,真空干燥后得到92.3mg淡黄色固体。
本发明实施例1-2合成的新型二茂铁吡啶衍生物FeL1-2通过1H NMR,13C{H}NMR和MS手段进行了结构鉴定,证实其结构为以上结构式所标示。
实施例三
二茂铁吡啶衍生物FeL1和FeL2对与Cu2+和Cr3+的选择性相互作用向10μM的二茂铁单臂吡啶衍生物FeL1的乙醇溶液中分别滴加100mM的Cu2+和100mM的Cr3+,样品分别对应标号为A和B;控制离子的Cu2+和Cr3+的最终浓度依次是0,10,20,40,60,80,100,120,150,180,200μM,样品对应标号为英文字母a到k。采用紫外分光光度法,检测滴加前后的紫外-可见光吸收光谱的变化。分别得到如图1A和B所示的紫外滴定曲线。
向10μM的二茂铁双臂吡啶衍生物FeL2的乙醇溶液中分别滴加100mM的Gu2+和100mM的Cr3+,样品分别对应标号为C和D;控制离子的Cu2+和Cr3+的最终浓度依次是0,10,20,40,60,80,100,120,150,180,200μM,样品对应标号为英文字母a到k。采用紫外分光光度法,检测滴加前后的紫外-可见光吸收光谱的变化,分别得到如图1C和D所示的紫外滴定曲线。
实施例四
混合离子对二茂铁吡啶衍生物FeL1和FeL2特异性识别Cu2+和Cr3+的干扰检测
向10μM的二茂铁单臂吡啶衍生物FeL1的乙醇溶液中滴加100mM的13种混合离子溶液,包括:k+,Na+,Ba2+,Mg2+,Ca2+,Sr2+,Zn2+,Co2+,Ni2+,Mn2+,Cd2+,Hg2+,Pd2+,控制混合离子溶液的最终浓度依次是0,100,200,300,400,500,600μM,样品对应标号为英文字母a到g;
再继续向此溶液中分别滴加100mM的Cu2+和100mM的Cr3+,样品分别对应标号为A和B;控制离子的Cu2+和Cr3+的最终浓度依次是100,200,300,400,500μM,样品对应标号为英文字母h到1;
采用紫外分光光度法,检测滴加前后的紫外-可见光吸收光谱的变化,分别得到如图2A和B所示的紫外滴定曲线。
向10μM的二茂铁双臂吡啶衍生物FeL2的乙醇溶液中滴加100mM的13种混合离子溶液,包括:k+,Na+,Ba2+,Mg2+,Ca2+,Sr2+,Zn2+,Co2+,Ni2+,Mn2+,Cd2+,Hg2+,Pd2+,控制混合离子溶液的最终浓度依次是0,100,200,300,400,500,600μM,样品对应标号为英文字母a到g;
向10μM的二茂铁双臂吡啶衍生物FeL2的乙醇溶液中分别滴加100mM的Cu2+和100mM的Cr3+,样品分别对应标号为C和D;控制离子的Cu2+和Cr3+的最终浓度依次是100,200,300,400,500μM,样品对应标号为英文字母h到l;
采用紫外分光光度法,检测滴加前后的紫外-可见光吸收光谱的变化,分别得到如图2C和D所示的紫外滴定曲线。
实施例五
二茂铁吡啶衍生物FeL1、FeL2特异性识别Cu2+和Cr3+的实际应用
分别取10μM的二茂铁单臂吡啶衍生物FeL1、二茂铁双臂吡啶衍生物FeL2的乙醇溶液,样品对应标号分别为A和B,向其中滴加50.25mM的15种混合离子水溶液,包括:k+,Na+,Ba2+,Mg2+,Ca2+,Sr2+,Zn2+,Co2+,Ni2+,Mn2+,Cd2+,Hg2+,Pd2+,Cr3+,Cu2+,滴定中混合离子溶液的终浓度依次是0,50.25,100.5,150.75,201,251.25,301.5,351.75,402,452.25,502.5μM,样品对应标号为英文字母a到k。
采用紫外分光光度法,检测滴加前后的紫外-可见光吸收光谱的变化,二茂铁衍生物FeL1,FeL2,FeL3,FeL4分别得到如图3A和B所示的紫外滴定曲线。
实施例六
将3.6mg二茂铁单臂吡啶衍生物FeL1溶解在500uL氘代甲醇溶液中,逐滴加入1MCrCl3·6H2O氘代水储存溶液,通过核磁滴定,检测二茂铁单臂吡啶衍生物FeL1与Cr3+的相互作用,得到如图4所示的核磁氢谱滴定图。其中,0e和5e分别代表金属离子浓度为二茂铁单臂吡啶衍生物FeL1浓度的0倍和5倍。
实施例七
配置体积浓度比为4∶1的氘代甲醇和DMSO-d6混合液,将二茂铁单臂吡啶衍生物FeL1溶解在氘代甲醇和DMSO-d6混合液中,向同浓度的二茂铁单臂吡啶衍生物FeL1混合溶液中中依次滴加0-5倍的Cu2+,通过核磁滴定,得到如图5所示的核磁氢谱滴定图。其中,0e、0.5e和5e分别代表金属离子浓度为二茂铁单臂吡啶衍生物FeL1浓度的0倍、0.5倍和5倍。
实施例八
配置体积比为4∶1的氘代甲醇和DMSO-d6混合液,将二茂铁双臂吡啶衍生物FeL2溶解在氘代甲醇和DMSO-d6混合液中,向同浓度的二茂铁双臂吡啶衍生物FeL2混合溶液中依次滴加0-5倍的Cu2+和Cr3+,其中,Cu2+和Cr3+的浓度比例为1∶1,通过核磁滴定,得到如图6所示的核磁氢谱滴定图。其中,0e、0.5e和5e分别代表金属离子浓度为二茂铁双臂吡啶衍生物FeL2浓度的0倍、0.5倍和5倍。
由图1可知,Cu2+的加入使二茂铁吡啶衍生物FeL1和FeL2紫外曲线出现了明显的变化,在250nm处的吸光度值随着Cu2+加入量的增加而增大,在310nm左右的吸收峰逐渐蓝移至290nm左右。当滴加Cr3+后,310nm处的吸收峰迁移至317nm,并且在345nm处出现了新的紫外吸收峰,而在251nm处的吸收峰也有明显的增色效应。重要的是在滴加其它金属离子后,化合物的紫外吸收曲线没有明显变化。
结果表明,二茂铁吡啶衍生物FeL1和FeL2对两种金属离子即Cu2+和Cr3+有识别作用。
由图2可知,向10μM的FeL1乙醇溶液中滴加不包括Cu2+和Cr3+的13种混合离子混合离子(所述混合离子为不包括Cu2+和Cr3+的13种混合离子:k+,Na+,Ba2+,Mg2+,Ca2+,Sr2+,Zn2+,Co2+,Ni2+,Mn2+,Cd2+,Hg2+,Pd2+),当加入的离子量为FeLl量的12倍,混合离子终浓度达120μM时,并没有发现FeL1的紫外吸收曲线有明显变化,只是250nm处吸收峰有弱的增色。而当再滴加铜离子后,310nm处的吸收峰逐渐蓝移至290nm左右,同时250nm处的吸收峰出现很强的增色效应,这说明其它金属离子并不影响FeL1对铜离子的选择性识别。在相同的实验条件下,加混合离子的溶液中再加入铬离子,FeL1的紫外吸收曲线发生明显变化,310nm处的吸收峰几乎消失,同时338nm处出现了明显的新紫外吸收峰。这同样说明FeL1对铬离子有很好的选择性作用,能够应用于实际检测中去。通过同样的方法,向10μM FeL2的乙醇溶液中逐步滴加混合离子(所述混合离子为不包括Cu2+和Cr3+的13种混合离子:k+,Na+,Ba2+,Mg2+,Ca2+,Sr2+,Zn2+,Co2+,Ni2+,Mn2+,Cd2+,Hg2+,Pd2+),FeL2的紫外吸收也没有明显变化。当加入铜离子后,310nm的紫外吸收峰逐渐蓝移至290nm左右,250nm处的吸收峰有很强的的增色效应。当加入铬离子后,310nm的吸收峰红移至315nm,并在338nm处出现一新吸收峰。
结果表明,只要有铜离子的存在,不论FeL1还是FeL2,都有共同的变化特征:即310nm的吸收峰发生蓝移至290nm左右,并且250nm处有很强的增色效应;只要有铬离子的存在,都会在338nm处出现新的吸收峰。
实际应用中的混合离子可能同时包含铜离子和铬离子。为研究这类二茂铁衍生物在实际复杂体系中的选择性,我们配制了包括铜离子和铬离子在内的15种混合离子溶液,即含k+,Na+,Ba2+,Mg2+,Ca2+,Sr2+,Zn2+,Co2+,Ni2+,Mn2+,Cd2+,Hg2+,Pd2+,Cr3+,Cu2+等15种混合离子。如图3所示,当滴加入15种混合离子后,对于二茂铁吡啶单臂衍生物FeL1和二茂铁吡啶双臂衍生物FeL2,出现了两处明显变化:一是310nm处的峰蓝移至290nm左右,说明铜离子的存在;二是348nm出现一新的紫外吸收峰,说明铬离子的存在。这种变化在离子浓度低至12.56μM便可发生。
如图4所示,FeL1氘代甲醇溶液加入铬离子后,7.41ppm处的三重峰向低场迁移到7.62ppm(Δδ=0.21ppm),7.05和7.07的双重峰向高场迁移到6.74ppm(Δδ=0.31和0.33),6.22和6.24处的双重峰向低场迁移到6.42ppm(Δδ=0.22和0.18),3.78处单峰迁移到了3.85。结果表明,铬离子与化合物FeL1有明显的相互作用,且与铬离子配位的原子很可能是吡啶α位的氮及氨基甲酸酯基团上的氧。
在研究FeL1氘代甲醇溶液与Cu2+作用时,我们发现,滴加Cu2+后所有的核磁峰都消失了。经过分析,我们认为这可能是络合物在甲醇中溶解度过小造成的。因此,我们换用氘代甲醇和DMSO-d6混合溶液进行检测,如图5,向同浓度的化合物FeL1中依次滴加0-5倍的Cu2 +,发现7.40、7.42和7.44处的三重峰迁移到了7.21(Δδ=0.19、0.21和0.23),7.08和7.10的双重峰迁移到了7.04(Δδ=0.04和0.06),6.24和6.26处的双重峰迁移到了6.17(Δδ=0.07和0.09)。这里氢谱峰都略向高场迁移,这说明铜离子很可能是和吡啶α位酰胺上的氮配位,从而影响了酰胺的共轭状态。
其它化合物在氘代甲醇中的溶解性都不好,因此,这些化合物的核磁滴定都选择在氘代甲醇和DMSO-d6混合溶液中进行。
图6表明,向化合物FeL2滴加0-5倍的Cu2+,吡啶环上的氢谱峰都略向高场迁移.滴加Cr3+后,吡啶环上的a峰和b峰都略向低场迁移,而c略向高场迁移,这和FeL1与铬离子和铜离子作用的核磁迁移是一致的。
以上实施例的说明只是用于帮助理解本发明的方法及其核心思想。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以对本发明进行若干改进和修饰,这些改进和修饰也落入本发明权利要求的保护范围内。
Claims (10)
1.一种二茂铁吡啶衍生物,其化学结构式为:
。
2.如权利要求1所述的二茂铁吡啶衍生物的制备方法,其包括:将二茂铁甲醛在三乙酰氧基硼氢化钠作用下,与2-氨基甲酸甲酯基-6-氨基吡啶反应得到。
3.如权利要求2所述的二茂铁吡啶衍生物的制备方法,其包括以下步骤:
a)将二茂铁甲醛和2-氨基甲酸甲酯基-6-氨基吡啶溶于干燥的CH2Cl2;
b)加入三乙酰氧基硼氢化钠;
c)加入三乙胺,调节pH为5-6;
d)加热回流过夜,冷却至室温,旋蒸,CH2Cl2溶解残留物依次用饱和NaHCO3溶液,饱和NaCl溶液,H2O洗涤有机相,无水Na2SO4干燥,过滤旋蒸,得到橙黄色固体粗产物;
e)硅胶柱层析纯化,干燥后得到淡黄色固体。
4.一种二茂铁吡啶衍生物,其化学结构式为:
。
5.如权利要求4所述的二茂铁吡啶衍生物的制备方法,其包括:将二茂铁二甲醛在三乙酰氧基硼氢化钠作用下,与2-氨基甲酸甲酯基-6-氨基吡啶反应得到。
6.如权利要求5所述的二茂铁吡啶衍生物的制备方法,其包括以下步骤:
a)将二茂铁二甲醛和2-氨基甲酸甲酯基-6-氨基吡啶溶于干燥的CH2Cl2;
b)加入三乙酰氧基硼氢化钠;
c)加入三乙胺,调节pH为5-6;
d)加热回流过夜,冷却至室温,旋蒸,CH2Cl2溶解残留物依次用饱和NaHCO3溶液,饱和NaCl溶液,H2O洗涤有机相,无水Na2SO4干燥,过滤旋蒸,得到橙黄色固体粗产物;
e)硅胶柱层析纯化,干燥后得到淡黄色固体。
7.如权利要求1或4所述二茂铁吡啶衍生物,其在Cu2+和Cr3+的检测中的应用。
8.如权利要求7所述二茂铁吡啶衍生物在Cu2+和Cr3+的检测中的应用,其特征在于:采用紫外分光光度法检测Cu2+和Cr3+。
9.如权利要求7所述二茂铁吡啶衍生物在Cu2+和Cr3+的检测中的应用,其特征在于:采用核磁滴定法检测Cu2+和Cr3+。
10.如权利要求9所述二茂铁吡啶衍生物在Cu2+和Cr3+的检测中的应用,其特征在于:所述核磁滴定法在氘代甲醇,或者氘代甲醇和DMSO-d6混合溶液中进行。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510048462.5A CN104610381B (zh) | 2015-01-30 | 2015-01-30 | 二茂铁吡啶衍生物及其合成方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510048462.5A CN104610381B (zh) | 2015-01-30 | 2015-01-30 | 二茂铁吡啶衍生物及其合成方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104610381A CN104610381A (zh) | 2015-05-13 |
CN104610381B true CN104610381B (zh) | 2017-04-12 |
Family
ID=53145058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510048462.5A Expired - Fee Related CN104610381B (zh) | 2015-01-30 | 2015-01-30 | 二茂铁吡啶衍生物及其合成方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104610381B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107999073B (zh) * | 2017-12-12 | 2020-10-23 | 泰州禾益新材料科技有限公司 | 一种甲醛乙炔化反应催化剂的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104292274A (zh) * | 2013-07-17 | 2015-01-21 | 湖北大学 | 一种二茂铁萘啶衍生物及其制备和应用 |
-
2015
- 2015-01-30 CN CN201510048462.5A patent/CN104610381B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104292274A (zh) * | 2013-07-17 | 2015-01-21 | 湖北大学 | 一种二茂铁萘啶衍生物及其制备和应用 |
Non-Patent Citations (1)
Title |
---|
Pentacarbonyl(2,6-diaininopyridine)chromium(0):synthesis and molecular structure;Morkan I. A. et al.;《Journal of Organometallic Chemistry》;20041231;第2319-2323页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104610381A (zh) | 2015-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yu et al. | “Off-On” based fluorescent chemosensor for Cu2+ in aqueous media and living cells | |
Benítez et al. | Design of vanadium mixed-ligand complexes as potential anti-protozoa agents | |
Nunez et al. | New rhodamine dimer probes for mercury detection via color changes and enhancement of the fluorescence emission: Fast recognition in cellulose supported devices | |
CN103013495B (zh) | 一种铜离子荧光探针及其合成方法 | |
Fan et al. | A fluorescent probe for the dual-channel detection of Hg2+/Ag+ and its Hg2+-based complex for detection of mercapto biomolecules with a tunable measuring range | |
Asaithambi et al. | Ratiometric sensing of sulfite/bisulfite ions and its applications in food samples and living cells | |
CN106046059B (zh) | 一种具有线粒体靶向功能的磷光铱配合物探针及其制备和应用 | |
CN112939957B (zh) | 一种苯并吲哚衍生物In-XY1及其合成方法和应用 | |
Li et al. | Colorimetric and fluorometric dual-modal probes for cyanide detection based on the doubly activated Michael acceptor and their bioimaging applications | |
Datta et al. | Selective fluorescence sensor for Al3+ and Pb2+ in physiological condition by a benzene based tripodal receptor | |
CN110183430A (zh) | 含磺酰胺的4-(n-甲基)氨基哌啶杨梅素衍生物、制备方法及用途 | |
CN104610381B (zh) | 二茂铁吡啶衍生物及其合成方法和应用 | |
CN102818802A (zh) | 一种检测次氯酸根的方法 | |
Dhaka et al. | Spectral studies on benzimidazole-based “bare-eye” probe for the detection of Ni2+: Application as a solid state sensor | |
Erdemir et al. | Fast, visual, and quantitative monitoring of N2H4 by two ratiometric fluorescent probes in environmental media and biological systems | |
Wang et al. | A dual-responsive Ni (II) coordination polymer fluorescent sensor: Rare turn-on detection of ascorbic acid and turn-off sensing acetylacetone | |
CN111892923A (zh) | 一种基于二腈乙烯基的双光子荧光粘度探针及其制备方法和用途 | |
Queiroz et al. | Synthesis and antioxidant activity evaluation of new 7-aryl or 7-heteroarylamino-2, 3-dimethylbenzo [b] thiophenes obtained by Buchwald–Hartwig C–N cross-coupling | |
CN110204535A (zh) | 一种香豆素类水合肼荧光探针及其制备方法 | |
CN110283100A (zh) | 一种化合物、制备方法及作为肼荧光探针的应用 | |
CN107417732A (zh) | 一种有机配合物汞离子探针及其制备方法与应用 | |
Dalapati et al. | Reusable anion detection kit: An aqueous medium anion detection | |
Guan et al. | Two fluorescence turn-on chemosensors for cyanide anions based on pyridine cation and the boronic acid moiety | |
CN104946244B (zh) | 检测o2·‑的荧光分子探针、其合成方法和应用 | |
Zhang et al. | A novel amino functionalized three-dimensional fluorescent Zn-MOF: The synthesis, structure and applications in the fluorescent sensing of organic water pollutants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170412 Termination date: 20190130 |